High-dose mouse immunoglobulin G administration suppresses Theiler's murine encephalomyelitis virus-induced demyelinating disease

Citation
Cs. Koh et al., High-dose mouse immunoglobulin G administration suppresses Theiler's murine encephalomyelitis virus-induced demyelinating disease, J NEUROIMM, 108(1-2), 2000, pp. 22-28
Citations number
26
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEUROIMMUNOLOGY
ISSN journal
01655728 → ACNP
Volume
108
Issue
1-2
Year of publication
2000
Pages
22 - 28
Database
ISI
SICI code
0165-5728(20000801)108:1-2<22:HMIGAS>2.0.ZU;2-J
Abstract
We studied the effect of high-dose mouse Ige on TMEV-induced demyelinating disease (TMEV-IDD). We injected TMEV intracerebrally into susceptible SJL/J mice and induced TMEV-IDD. Mouse IgG were injected intraperitonealy, and c linical course and various immunological indicators were studied. The resul ts show that TMEV-IDD was significantly suppressed both clinically and hist ologically (P<0.01) when IgG were administered in the effector phase. The d elayed type hypersensitivity and T cell proliferative response specific for TMEV were decreased by this treatment. In an ELISPOT assay, the number of TNF-alpha producing lymphocytes in the spinal cords was low in high-dose Ig G treated mice compared with PBS treated control mice. These data suggest t hat administration of IgG suppresses TMEV-IDD and may be promising treatmen t to prevent exacerbation of human multiple sclerosis. (C) 2000 Elsevier Sc ience B.V. All rights reserved.